Abstract
AbstractThe Brazilian Society of Pathology Guidelines project aims to provide recommendations for clinicians and pathologists based on the best available scientific evidence adapted from the International Guidelines, with emphasis in the practice of Brazilian pathologists. It reviews currently available and emerging molecular tests. In this paper, a combined effort from members of the Brazilian Society of Pathology describes the essential pre-analytical issues, the required clinical information to allow proper molecular testing interpretation, and the important role of pathologists in multidisciplinary tumor boards.
Publisher
Springer Science and Business Media LLC